ZimVie (ZIMV) Competitors $18.80 +0.07 (+0.35%) As of 03:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ZIMV vs. INMD, SSII, KMTS, IRMD, SIBN, SMLR, EMBC, CBLL, BVS, and BBNXShould you be buying ZimVie stock or one of its competitors? The main competitors of ZimVie include InMode (INMD), SS Innovations International (SSII), Kestra Medical Technologies (KMTS), iRadimed (IRMD), SiBone (SIBN), Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), Bioventus (BVS), and Beta Bionics (BBNX). These companies are all part of the "medical equipment" industry. ZimVie vs. Its Competitors InMode SS Innovations International Kestra Medical Technologies iRadimed SiBone Semler Scientific Embecta CeriBell Bioventus Beta Bionics InMode (NASDAQ:INMD) and ZimVie (NASDAQ:ZIMV) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Do analysts prefer INMD or ZIMV? InMode presently has a consensus target price of $18.54, suggesting a potential upside of 25.24%. ZimVie has a consensus target price of $17.00, suggesting a potential downside of 9.55%. Given InMode's higher possible upside, equities analysts plainly believe InMode is more favorable than ZimVie.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score InMode 0 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.13ZimVie 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50 Which has preferable valuation & earnings, INMD or ZIMV? InMode has higher earnings, but lower revenue than ZimVie. ZimVie is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInMode$394.82M2.37$181.27M$2.336.35ZimVie$443.55M1.18-$25.83M-$0.71-26.47 Does the media prefer INMD or ZIMV? In the previous week, ZimVie had 13 more articles in the media than InMode. MarketBeat recorded 16 mentions for ZimVie and 3 mentions for InMode. InMode's average media sentiment score of 1.58 beat ZimVie's score of 0.60 indicating that InMode is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive ZimVie 4 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is INMD or ZIMV more profitable? InMode has a net margin of 44.79% compared to ZimVie's net margin of -4.40%. InMode's return on equity of 17.17% beat ZimVie's return on equity.Company Net Margins Return on Equity Return on Assets InMode44.79% 17.17% 15.20% ZimVie -4.40%5.53%2.84% Which has more risk and volatility, INMD or ZIMV? InMode has a beta of 1.95, indicating that its share price is 95% more volatile than the S&P 500. Comparatively, ZimVie has a beta of 2.07, indicating that its share price is 107% more volatile than the S&P 500. Do institutionals & insiders have more ownership in INMD or ZIMV? 68.0% of InMode shares are owned by institutional investors. Comparatively, 95.6% of ZimVie shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 3.0% of ZimVie shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummaryInMode beats ZimVie on 11 of the 17 factors compared between the two stocks. Get ZimVie News Delivered to You Automatically Sign up to receive the latest news and ratings for ZIMV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ZIMV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ZIMV vs. The Competition Export to ExcelMetricZimVieMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$523.38M$10.48B$5.66B$9.45BDividend YieldN/A2.06%4.01%4.02%P/E Ratio-26.4717.6628.5520.10Price / Sales1.1828.29417.2988.13Price / Cash10.1022.4235.9658.29Price / Book1.363.708.545.79Net Income-$25.83M$234.77M$3.24B$258.18M7 Day Performance115.54%6.40%4.75%3.80%1 Month Performance117.28%11.20%12.89%14.59%1 Year Performance-14.37%-15.14%36.03%18.91% ZimVie Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ZIMVZimVie0.6553 of 5 stars$18.80+0.3%$17.00-9.6%-13.8%$523.38M$443.55M-26.471,770Analyst UpgradeHigh Trading VolumeINMDInMode4.0904 of 5 stars$14.74+0.2%$18.54+25.8%-18.8%$931.70M$392.41M6.33480Positive NewsUpcoming EarningsSSIISS Innovations InternationalN/A$4.75-4.8%N/AN/A$919.60M$20.65M0.004News CoverageGap DownKMTSKestra Medical TechnologiesN/A$15.43+3.5%$27.50+78.2%N/A$792.32M$52.64M0.00300IRMDiRadimed4.5421 of 5 stars$58.07+0.9%$72.00+24.0%+22.2%$738.65M$73.24M37.46110Upcoming EarningsSIBNSiBone2.9586 of 5 stars$17.32+0.7%$22.50+29.9%+2.1%$738.18M$167.18M-27.06350SMLRSemler Scientific2.6904 of 5 stars$45.23-0.7%$89.00+96.8%+17.3%$619.20M$56.29M-17.33120EMBCEmbecta4.5786 of 5 stars$10.37-1.0%$19.33+86.4%-29.6%$606.05M$1.08B11.522,100CBLLCeriBell2.0494 of 5 stars$16.38+1.5%$32.14+96.2%N/A$591.97M$65.44M0.00N/ABVSBioventus3.0598 of 5 stars$6.81-2.3%$13.75+101.9%-12.5%$559.40M$567.70M-11.161,200BBNXBeta BionicsN/A$12.83+1.3%$23.44+82.7%N/A$556.31M$65.12M0.00294News CoveragePositive News Related Companies and Tools Related Companies InMode Competitors SS Innovations International Competitors Kestra Medical Technologies Competitors iRadimed Competitors SiBone Competitors Semler Scientific Competitors Embecta Competitors CeriBell Competitors Bioventus Competitors Beta Bionics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ZIMV) was last updated on 7/23/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?Bitcoin is breaking out — and one state just created a Strategic Crypto Reserve. James Altucher says this m...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZimVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ZimVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZIMV Stock Alerts